ATXN1 Mouse Monoclonal Antibody, Unconjugated

Catalog Number: EKL-AMM80932
Article Name: ATXN1 Mouse Monoclonal Antibody, Unconjugated
Biozol Catalog Number: EKL-AMM80932
Supplier Catalog Number: AMM80932
Alternative Catalog Number: EKL-AMM80932-50UL,EKL-AMM80932-100UL
Manufacturer: EnkiLife
Host: Mouse
Category: Antikörper
Application: ELISA, FC, ICC, IHC
Species Reactivity: Human
Conjugation: Unconjugated
Alternative Names: ATX1, SCA1, D6S504E, ATXN1
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the pure cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 41-81 CAG repeats, compared to 6-39 in the normal allele. At least two transcript variants encoding the same protein have been found for this gene.Tissue specificity: Widely expressed throughout the body.
Clonality: Monoclonal
Molecular Weight: 87kDa
NCBI: 6310
UniProt: P54253
Buffer: Ascitic fluid containing 0.03% sodium azide.
Purity: Affinity Purification
Form: Liquid
Target: ATXN1
Application Dilute: IHC 1:200-1:1000,ICC 1:200-1:1000,ELISA 1:5000-1:20000,FC 1:200-1:400